Beste Karen Jagoda Podcasts (2024)

1
Voter Behavior in a Time of Political and Economic Uncertainty with Andrew Einhorn LevelFields 24:47

12h ago24:47

24:47

Andrew Einhorn, the Co-Founder and CEO of LevelFields, is an expert on fintech and AI. He highlights how political uncertainty and tight elections create market volatility and can impact voting behavior. Using their event intelligence platform, LevelFields connects the dots using AI to spot trends and predict future behavior. We talk about: How the…

1
Strategies for Employers to Navigate the Complex Pharmaceutical Landscape with Dr. Mark Campbell RxBenefits TRANSCRIPT

20h ago

—

Dr. Mark Campbell, Chief Pharmacy Officer at RxBenefits, a prescription benefit optimizer that works with self-funded employers to help them get the best clinical and economic value from their pharmacy benefit manager relationships. As the healthcare landscape has become more complex with the rise of specialty and high-cost drugs, a significant por…

1
Strategies for Employers to Navigate the Complex Pharmaceutical Landscape with Dr. Mark Campbell RxBenefits 20:35

20h ago20:35

20:35

Dr. Mark Campbell, Chief Pharmacy Officer at RxBenefits, a prescription benefit optimizer that works with self-funded employers to help them get the best clinical and economic value from their pharmacy benefit manager relationships. As the healthcare landscape has become more complex with the rise of specialty and high-cost drugs, a significant por…

1
AI-Powered Retinal Imaging Unlocks Biomarkers for Early-Stage Diseases with Dr. Vicky Demas identifeye HEALTH TRANSCRIPT

1d ago

—

Dr. Vicky Demas, CEO of identifeye HEALTH, is using AI-powered diagnostic algorithms and automation to improve the accessibility and quality of retinal imaging, focusing on the early detection of diabetic retinopathy. The identifeye technology makes it easier for patients to get screened for eye conditions in primary care or retail settings. The go…

1
AI-Powered Retinal Imaging Unlocks Biomarkers for Early-Stage Diseases with Dr. Vicky Demas identifeye HEALTH 19:28

1d ago19:28

19:28

Dr. Vicky Demas, CEO of identifeye HEALTH, is using AI-powered diagnostic algorithms and automation to improve the accessibility and quality of retinal imaging, focusing on the early detection of diabetic retinopathy. The identifeye technology makes it easier for patients to get screened for eye conditions in primary care or retail settings. The go…

1
Raising Awareness About Safe Practices and Opportunities for IV Therapy with Felicia Janovich American IV Association TRANSCRIPT

3d ago

—

Felicia Janovich is a founding member of the American IV Association, which advocates for safe and effective IV therapies, including hydration, vitamin infusions, and treatments to support patients with chronic conditions or undergoing chemotherapy. While there is limited research on the effectiveness of these IV therapies, AIVA is working to colle…

1
Raising Awareness About Safe Practices and Opportunities for IV Therapy with Felicia Janovich American IV Association 20:29

3d ago20:29

20:29

Felicia Janovich is a founding member of the American IV Association, which advocates for safe and effective IV therapies, including hydration, vitamin infusions, and treatments to support patients with chronic conditions or undergoing chemotherapy. While there is limited research on the effectiveness of these IV therapies, AIVA is working to colle…

1
Tolerable Oral Alzheimer’s Medication to Manage Symptoms Slow Progression with Michael McFadden Alpha Cognition TRANSCRIPT

6d ago

—

Michael McFadden is the CEO of Alpha Cognition, a biopharmaceutical company focused on developing treatments for brain diseases such as Alzheimer's, ALS, and traumatic brain injury. Their drug ZUNVEYL, recently approved by the FDA, is an oral treatment for mild to moderate Alzheimer's that improves symptoms such as memory loss, mental processing sp…

1
Tolerable Oral Alzheimer’s Medication to Manage Symptoms Slow Progression with Michael McFadden Alpha Cognition 19:02

6d ago19:02

19:02

Michael McFadden is the CEO of Alpha Cognition, a biopharmaceutical company focused on developing treatments for brain diseases such as Alzheimer's, ALS, and traumatic brain injury. Their drug ZUNVEYL, recently approved by the FDA, is an oral treatment for mild to moderate Alzheimer's that improves symptoms such as memory loss, mental processing sp…

1
Robust Cybersecurity Risk Management in the Healthcare Ecosystem with George Pappas Intraprise Health TRANSCRIPT

7d ago

—

George Pappas, CEO of Intraprise Health, works with various healthcare organizations across the healthcare industry and healthcare ecosystem to help address cybersecurity risks. While recent cyber attacks have raised awareness about the need for better cybersecurity measures, the complexity of healthcare IT systems creates significant challenges fo…

1
Robust Cybersecurity Risk Management in the Healthcare Ecosystem with George Pappas Intraprise Health 18:27

7d ago18:27

18:27

George Pappas, CEO of Intraprise Health, works with various healthcare organizations across the healthcare industry and healthcare ecosystem to help address cybersecurity risks. While recent cyber attacks have raised awareness about the need for better cybersecurity measures, the complexity of healthcare IT systems creates significant challenges fo…

1
Developing Non-Opioid Pain Medication with Reduced Abuse Potential with Ketan Mehta Tris Pharma TRANSCRIPT

8d ago

—

Ketan Mehta, Founder and CEO of Tris Pharma, is focused on developing non-addictive pain medication. Their lead drug candidate is designed to be an effective pain drug without the respiratory-depressive and addictive side effects of traditional opioid drugs. This drug works by targeting the nociceptin receptor and has also shown promise to help cur…

1
Developing Non-Opioid Pain Medication with Reduced Abuse Potential with Ketan Mehta Tris Pharma 18:53

8d ago18:53

18:53

Ketan Mehta, Founder and CEO of Tris Pharma, is focused on developing non-addictive pain medication. Their lead drug candidate is designed to be an effective pain drug without the respiratory-depressive and addictive side effects of traditional opioid drugs. This drug works by targeting the nociceptin receptor and has also shown promise to help cur…

1
Proactive Management of Chronic GI Conditions with Beth Houck SonarMD TRANSCRIPT

9d ago

—

Beth Houck, Chief Executive Officer at SonarMD, works with payers and physician practices to provide proactive, value-based care for patients with chronic GI conditions. They use a digital platform to monitor self-reported patient symptoms and enable physicians to identify those patients that need attention. This approach aims to improve patient ou…

1
Proactive Management of Chronic GI Conditions with Beth Houck SonarMD 18:06

9d ago18:06

18:06

Beth Houck, Chief Executive Officer at SonarMD, works with payers and physician practices to provide proactive, value-based care for patients with chronic GI conditions. They use a digital platform to monitor self-reported patient symptoms and enable physicians to identify those patients that need attention. This approach aims to improve patient ou…

1
How Generative AI is Unlocking Insights to Expand Drug Development with Dr. Chris Bouton Certara TRANSCRIPT

10d ago

—

Dr. Chris Bouton, the Senior VP and Head of Artificial Intelligence at Certara, is exploring applying generative AI to drug discovery and development to improve efficiency and identify novel therapeutics across various use cases. The focus is on developing specialized secure AI models to integrate internal data with the Certara platform. Generative…

1
How Generative AI is Unlocking Insights to Expand Drug Development with Dr. Chris Bouton Certara 19:27

10d ago19:27

19:27

Dr. Chris Bouton, the Senior VP and Head of Artificial Intelligence at Certara, is exploring applying generative AI to drug discovery and development to improve efficiency and identify novel therapeutics across various use cases. The focus is on developing specialized secure AI models to integrate internal data with the Certara platform. Generative…

1
Unique Fat-Inhibiting Approach Targets Multiple Pathways in Metabolic Liver Disease with David Happel Sagimet Biosciences TRANSCRIPT

13d ago

—

David Happel is President and CEO of Sagimet Biosciences, a company developing drugs to treat metabolic diseases by targeting the underlying cause of fat accumulation in the liver. The drug denifanstat limits the activity of fatty acid synthase (FASN), an enzyme that regulates fat accumulation. This approach is a fat inhibitor, not a fat burner, th…

1
Unique Fat-Inhibiting Approach Targets Multiple Pathways in Metabolic Liver Disease with David Happel Sagimet Biosciences 24:15

13d ago24:15

24:15

David Happel is President and CEO of Sagimet Biosciences, a company developing drugs to treat metabolic diseases by targeting the underlying cause of fat accumulation in the liver. The drug denifanstat limits the activity of fatty acid synthase (FASN), an enzyme that regulates fat accumulation. This approach is a fat inhibitor, not a fat burner, th…

1
Untangling the Complexity of the 340B Drug Discount and Medicaid Drug Rebate Programs with Dr. Gavin Magaha Kalderos TRANSCRIPT

15d ago

—

Dr. Gavin Magaha, Senior Director for External Affairs and Policy at Kalderos, describes the 340B drug discount program created in 1992 to help safety net healthcare providers obtain discounted drugs. Over time, this program has grown in complexity, and issues have arisen around duplicate discounts where Medicaid rebates are involved. The current 3…

1
Untangling the Complexity of the 340B Drug Discount and Medicaid Drug Rebate Programs with Dr. Gavin Magaha Kalderos 19:05

15d ago19:05

19:05

Dr. Gavin Magaha, Senior Director for External Affairs and Policy at Kalderos, describes the 340B drug discount program created in 1992 to help safety net healthcare providers obtain discounted drugs. Over time, this program has grown in complexity, and issues have arisen around duplicate discounts where Medicaid rebates are involved. The current 3…

1
Using AI Big Data to Engineer More Efficient Drugs to Treat Rare and Common Diseases with Chris Hart Creyon Bio TRANSCRIPT

16d ago

—

Chris Hart, Co-Founder, CEO, and President of Creyon Bio, is focused on engineering drugs rather than just discovering them through serendipity and traditional methods. Creyon is developing oligonucleotide medicines for rare and common diseases by applying AI and big data models of the molecular and genetic basis of diseases to develop safe and eff…

1
Using AI Big Data to Engineer More Efficient Drugs to Treat Rare and Common Diseases with Chris Hart Creyon Bio 20:51

16d ago20:51

20:51

Chris Hart, Co-Founder, CEO, and President of Creyon Bio, is focused on engineering drugs rather than just discovering them through serendipity and traditional methods. Creyon is developing oligonucleotide medicines for rare and common diseases by applying AI and big data models of the molecular and genetic basis of diseases to develop safe and eff…

1
Palatable Elemental Diet Changes Management Options for GI Patients with Krystyna Houser mBIOTA Labs TRANSCRIPT

17d ago

—

Krystyna Houser is the Founder of mBIOTA Labs, a company that develops effective and tolerable elemental diets and medical foods for treating gastrointestinal disorders such as IBS, IBD, SIBO, IMO, and Crohn's disease. While short-term liquid elemental diets have been used in the past to treat GI conditions, the formulation has been very unpalatabl…

1
Palatable Elemental Diet Changes Management Options for GI Patients with Krystyna Houser mBIOTA Labs 15:23

17d ago15:23

15:23

Krystyna Houser is the Founder of mBIOTA Labs, a company that develops effective and tolerable elemental diets and medical foods for treating gastrointestinal disorders such as IBS, IBD, SIBO, IMO, and Crohn's disease. While short-term liquid elemental diets have been used in the past to treat GI conditions, the formulation has been very unpalatabl…

Podcasts, die es wert sind, gehört zu werden

Karen Jagoda Podcasts

Podcasts, die es wert sind, gehört zu werden

1
Digital Politics with Karen Jagoda

RadioActive

1
Empowered Patient Podcast

Karen Jagoda

1
Voter Behavior in a Time of Political and Economic Uncertainty with Andrew Einhorn LevelFields 24:47

1
Strategies for Employers to Navigate the Complex Pharmaceutical Landscape with Dr. Mark Campbell RxBenefits TRANSCRIPT

1
Strategies for Employers to Navigate the Complex Pharmaceutical Landscape with Dr. Mark Campbell RxBenefits 20:35

1
AI-Powered Retinal Imaging Unlocks Biomarkers for Early-Stage Diseases with Dr. Vicky Demas identifeye HEALTH TRANSCRIPT

1
AI-Powered Retinal Imaging Unlocks Biomarkers for Early-Stage Diseases with Dr. Vicky Demas identifeye HEALTH 19:28

1
Raising Awareness About Safe Practices and Opportunities for IV Therapy with Felicia Janovich American IV Association TRANSCRIPT

1
Raising Awareness About Safe Practices and Opportunities for IV Therapy with Felicia Janovich American IV Association 20:29

1
Tolerable Oral Alzheimer’s Medication to Manage Symptoms Slow Progression with Michael McFadden Alpha Cognition TRANSCRIPT

1
Tolerable Oral Alzheimer’s Medication to Manage Symptoms Slow Progression with Michael McFadden Alpha Cognition 19:02

1
Robust Cybersecurity Risk Management in the Healthcare Ecosystem with George Pappas Intraprise Health TRANSCRIPT

1
Robust Cybersecurity Risk Management in the Healthcare Ecosystem with George Pappas Intraprise Health 18:27

1
Developing Non-Opioid Pain Medication with Reduced Abuse Potential with Ketan Mehta Tris Pharma TRANSCRIPT

1
Developing Non-Opioid Pain Medication with Reduced Abuse Potential with Ketan Mehta Tris Pharma 18:53

1
Proactive Management of Chronic GI Conditions with Beth Houck SonarMD TRANSCRIPT

1
Proactive Management of Chronic GI Conditions with Beth Houck SonarMD 18:06

1
How Generative AI is Unlocking Insights to Expand Drug Development with Dr. Chris Bouton Certara TRANSCRIPT

1
How Generative AI is Unlocking Insights to Expand Drug Development with Dr. Chris Bouton Certara 19:27

1
Unique Fat-Inhibiting Approach Targets Multiple Pathways in Metabolic Liver Disease with David Happel Sagimet Biosciences TRANSCRIPT

1
Unique Fat-Inhibiting Approach Targets Multiple Pathways in Metabolic Liver Disease with David Happel Sagimet Biosciences 24:15

1
Untangling the Complexity of the 340B Drug Discount and Medicaid Drug Rebate Programs with Dr. Gavin Magaha Kalderos TRANSCRIPT

1
Untangling the Complexity of the 340B Drug Discount and Medicaid Drug Rebate Programs with Dr. Gavin Magaha Kalderos 19:05

1
Using AI Big Data to Engineer More Efficient Drugs to Treat Rare and Common Diseases with Chris Hart Creyon Bio TRANSCRIPT

1
Using AI Big Data to Engineer More Efficient Drugs to Treat Rare and Common Diseases with Chris Hart Creyon Bio 20:51

1
Palatable Elemental Diet Changes Management Options for GI Patients with Krystyna Houser mBIOTA Labs TRANSCRIPT

1
Palatable Elemental Diet Changes Management Options for GI Patients with Krystyna Houser mBIOTA Labs 15:23

Kurzanleitung